Biopsies guided by high resolution ultrasound are as effective as those using MRI in diagnosing prostate cancer, an international clinical trial has shown. The technology, called micro-ultrasound, is ...
Precisely delivered ultrasound could be an effective treatment for prostate cancer, with high-frequency sound waves heating and killing off cancer cells, a new study says. The treatment killed off all ...
18d
MaxQ Medical Raises $31.5 Million Series A, Backed by Olympus, to Advance its Prostate Care Platform
MaxQ Medical, Inc., a private health-tech company developing an all-in-one transurethral imaging and therapy system for prostate care, today announced the closing of a $31.5 million Series A financing ...
Biopsies guided by high resolution ultrasound are as effective as those using MRI in diagnosing prostate cancer, an international clinical trial has shown. The technology, called micro-ultrasound, is ...
TULSA reduces tumor volume and PSA levels, improving urinary and sexual function in prostate cancer patients. Five-year TACT study data shows 80% of patients had no significant disease after one year, ...
One in eight men will develop prostate cancer in their lifetime. Surgery to treat the disease can lead to unwelcome side effects. A minimally invasive alternative that avoids surgery is now available ...
Earlier this week, researchers presented data from the OPTIMUM (Optimization of Prostate Biopsy – Micro-Ultrasound Versus MRI) trial at the European Association of Urology Congress in Madrid, Spain.
A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and treat early prostate cancer while preserving patients' quality of life.
MaxQ’s namesake platform combines advanced imaging with tissue-selective therapy in a single transurethral procedure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results